Key Findings:  Resulting data showed that the administration of lower doses of CBD with trace amounts of THC appear to be a promising approach to manage behavioral problems associated with autism. More specifically, the authors report a decrease in behavioral problems (10 patients), an increase in expressive language (7 patients), improved cognition (4 patients), and an increase in social interaction (3 patients) for example.
Type of Study:  Clinical Trial
Study Sample Size:  33
Study Result:  Positive
Study Location(s):  Turkey
Year of Pub:  2021
Cannabinoids Studied:  Cannabidiol (CBD), Tetrahydrocannabinol (THC)
Phytocannabinoid Source:  Cannabis Flower derived
Chemotype:  Chemotype III
Dosage: CBD 0.3–2 mg/kg/day (with a maximum of 0.3% THC).
Route of Administration:  Oral (Ingestion)